It has previously been reported that YOD1 is closely associated with multiple tumors, including liver cancer, gallbladder cancer, pancreatic adenocarcinoma, acute promyelocytic leukemia, osteosarcoma, and ovarian cancer [27–32]. Here, YOD1 is linked to ovarian carcinoma.